Karuna Therapeutics (KRTX) SEC Filings & 10K Form

$329.83
0.00 (0.00%)
(As of 04/1/2024)

Recent Karuna Therapeutics SEC Filings

DateFilerForm TypeView
03/28/2024
3:06 PM
Karuna Therapeutics (Filer)
Form 15-12G
03/18/2024
3:30 PM
Brannan Stephen K. (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
3:30 PM
Kane William P Jr (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
3:30 PM
Karuna Therapeutics (Issuer)
Meury William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
3:30 PM
Brown Jason Parker (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
3:30 PM
COUGHLIN CHRISTOPHER J (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
3:30 PM
Karuna Therapeutics (Issuer)
PAUL STEVEN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
3:30 PM
Karuna Therapeutics (Issuer)
Miller Andrew Craig (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
3:30 PM
HEALY JAMES (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
3:30 PM
JONAS JEFFREY M (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
3:30 PM
Karuna Therapeutics (Issuer)
OLSON LAURIE J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
3:30 PM
Karuna Therapeutics (Issuer)
Pande Atul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
3:30 PM
Karuna Therapeutics (Issuer)
Torres Denice (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
3:31 PM
Karuna Therapeutics (Issuer)
Wheadon David E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
8:19 AM
Karuna Therapeutics (Filer)
Form S-8 POS
03/18/2024
8:19 AM
Karuna Therapeutics (Filer)
Form S-8 POS
03/18/2024
8:19 AM
Karuna Therapeutics (Filer)
Form S-8 POS
03/18/2024
8:19 AM
Karuna Therapeutics (Filer)
Form S-8 POS
03/18/2024
8:19 AM
Karuna Therapeutics (Filer)
Form S-8 POS
03/18/2024
8:04 AM
Karuna Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2024
8:08 AM
Karuna Therapeutics (Filer)
Form POSASR
03/18/2024
8:10 AM
Karuna Therapeutics (Subject)
Nasdaq Stock Market LLC (Filed by)
Form 25-NSE
03/14/2024
6:26 AM
Karuna Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2024
3:15 PM
Karuna Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2024
4:10 PM
Brannan Stephen K. (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:01 PM
Brannan Stephen K. (Reporting)
Karuna Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/01/2024
5:01 AM
Karuna Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/01/2024
5:02 AM
Karuna Therapeutics (Filer)
Form DEFA14A
02/26/2024
5:15 PM
Karuna Therapeutics (Issuer)
PAUL STEVEN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2024
5:39 AM
Karuna Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/22/2024
5:32 AM
Karuna Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/15/2024
3:42 PM
Karuna Therapeutics (Issuer)
Miller Andrew Craig (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
3:45 PM
Brown Jason Parker (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
3:50 PM
Brannan Stephen K. (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
3:53 PM
Kane William P Jr (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
3:37 PM
Karuna Therapeutics (Issuer)
Meury William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
4:09 PM
Brannan Stephen K. (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
4:11 PM
Karuna Therapeutics (Issuer)
Miller Andrew Craig (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
4:13 PM
Karuna Therapeutics (Issuer)
PAUL STEVEN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
11:03 AM
Karuna Therapeutics (Subject)
Form SC 13G/A
02/12/2024
11:25 AM
Capital International Investors (Filed by)
Karuna Therapeutics (Subject)
Form SC 13G/A
Protect Yourself While There’s Still Time … (Ad)

The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.

4 simple steps to protect your privacy and money before it’s too late.
02/09/2024
4:19 PM
Capital International Investors (Filed by)
Karuna Therapeutics (Subject)
Form SC 13G/A
02/08/2024
10:56 AM
Brannan Stephen K. (Reporting)
Karuna Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/05/2024
3:12 PM
Karuna Therapeutics (Filer)
Form DEFM14A
01/31/2024
1:08 PM
BlackRock Inc. (Filed by)
Karuna Therapeutics (Subject)
Form SC 13G
01/22/2024
5:05 AM
Karuna Therapeutics (Filer)
Form PREM14A
01/10/2024
7:53 AM
FMR LLC (Filed by)
Karuna Therapeutics (Subject)
Form SC 13G/A
01/09/2024
3:34 PM
Brannan Stephen K. (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
3:18 PM
Brannan Stephen K. (Reporting)
Karuna Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/29/2023
3:43 PM
Kane William P Jr (Reporting)
Karuna Therapeutics (Issuer)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/29/2023
3:42 PM
Karuna Therapeutics (Issuer)
Meury William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2023
5:09 PM
Ignelzi Troy A. (Reporting)
Karuna Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/22/2023
4:20 PM
Karuna Therapeutics (Filer)
Form DEFA14A
12/22/2023
4:20 PM
Karuna Therapeutics (Filer)
Form DEFA14A
12/22/2023
4:07 PM
Karuna Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/22/2023
3:36 PM
BRISTOL MYERS SQUIBB CO (Filed by)
Karuna Therapeutics (Subject)
Form DFAN14A
12/22/2023
3:21 PM
BRISTOL MYERS SQUIBB CO (Filed by)
Karuna Therapeutics (Subject)
Form DFAN14A
12/22/2023
3:22 PM
Karuna Therapeutics (Filer)
Form DEFA14A
12/22/2023
3:28 PM
Karuna Therapeutics (Filer)
Form DEFA14A
12/22/2023
7:31 AM
Karuna Therapeutics (Filer)
Form DEFA14A
12/22/2023
7:26 AM
Karuna Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/12/2023
3:56 PM
Brannan Stephen K. (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/08/2023
2:24 PM
Brannan Stephen K. (Reporting)
Karuna Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/06/2023
3:28 PM
Ignelzi Troy A. (Reporting)
Karuna Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/28/2023
4:39 PM
Ignelzi Troy A. (Reporting)
Karuna Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/21/2023
5:09 PM
Ignelzi Troy A. (Reporting)
Karuna Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/13/2023
4:15 PM
Brannan Stephen K. (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/02/2023
5:45 AM
Karuna Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/02/2023
5:36 AM
Karuna Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/10/2023
3:53 PM
Brannan Stephen K. (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2023
10:52 AM
Brannan Stephen K. (Reporting)
Karuna Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/03/2023
4:19 PM
Brown Jason Parker (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2023
4:05 PM
Brannan Stephen K. (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/08/2023
3:41 PM
Brannan Stephen K. (Reporting)
Karuna Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/05/2023
3:40 PM
JONAS JEFFREY M (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/24/2023
3:49 PM
Ignelzi Troy A. (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2023
4:14 PM
Ignelzi Troy A. (Reporting)
Karuna Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/03/2023
5:45 AM
Karuna Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/03/2023
5:37 AM
Karuna Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/02/2023
4:53 PM
JONAS JEFFREY M (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/07/2023
3:35 PM
BlackRock Inc. (Filed by)
Karuna Therapeutics (Subject)
Form SC 13G/A
07/05/2023
3:44 PM
JONAS JEFFREY M (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2023
3:02 PM
JONAS JEFFREY M (Reporting)
Karuna Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/03/2023
3:03 PM
Karuna Therapeutics (Subject)
OLSON LAURIE J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/22/2023
3:18 PM
Karuna Therapeutics (Issuer)
Wheadon David E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2023
3:07 PM
Karuna Therapeutics (Issuer)
OLSON LAURIE J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2023
3:09 PM
Karuna Therapeutics (Issuer)
Pande Atul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2023
3:11 PM
COUGHLIN CHRISTOPHER J (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2023
3:13 PM
JONAS JEFFREY M (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2023
3:16 PM
HEALY JAMES (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2023
4:15 PM
Karuna Therapeutics (Filer)
Form S-3ASR
Protect Yourself While There’s Still Time … (Ad)

The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.

4 simple steps to protect your privacy and money before it’s too late.
06/21/2023
3:05 PM
Karuna Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2023
7:56 PM
Karuna Therapeutics (Subject)
Sofinnova Venture Partners X, L.P. (Filed by)
Form SC 13D/A
06/20/2023
7:56 PM
HEALY JAMES (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2023
2:48 PM
Capital International Investors (Filed by)
Karuna Therapeutics (Subject)
Form SC 13G
05/23/2023
4:04 PM
Ignelzi Troy A. (Reporting)
Karuna Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/04/2023
5:49 AM
Karuna Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/04/2023
5:37 AM
Karuna Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/27/2023
6:12 AM
Karuna Therapeutics (Filer)
Form ARS
04/27/2023
5:58 AM
Karuna Therapeutics (Filer)
Form DEFA14A
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:KRTX) was last updated on 4/27/2024 by MarketBeat.com Staff

From Our Partners